Originally published by our sister publication Infectious Disease Special Edition
Protection from SARS-CoV-2 is extended with a messenger RNA (mRNA) booster. But that defense wanes over time, signaling the need for an additional booster, according to a large new study from the CDC.
Investigators at the CDC’s VISION Network analyzed data from nearly 893,500 patients (≥18 years of age) taken from 261 hospitals, 272 emergency departments and 119 urgent care clinics across 10 states between